tripeptide antioxidant
Glutathione
Answer
Glutathione is authorised or registered in the US, Canada and Brazil: 3 of the 10 registers read. Highest trial phase: Phase 4 (after approval). It has 276 registered trials, 44 of them running. Brand names on the FDA label register: Free Radical, Feelshion Dark Spot Remover Serum, Glutathione and Hepataplex.
RegulatorTrial register10 regulators' registers, read 2026-08-31 to 2026-10-03 · ClinicalTrials.gov and EU CTIS, read 2026-10-03
Not medical, legal or regulatory advice.
276 trials by status
Trial registerClinicalTrials.gov and EU CTIS · read 2026-10-03 · 11 trials have posted results
Trials first submitted per year
Trial registerClinicalTrials.gov first-submitted date, last 10 years · read 2026-10-03. 2026 is not complete. 128 trials carry no first-submitted date (EU CTIS publishes none, or the year is outside this range).
Status by jurisdiction
World map| Where | Status | Register | Read |
|---|---|---|---|
| United States | FDA-approved | FDA, openfda | 2026-10-03 |
| European Union | Not on the register | EMA, ema | 2026-08-31 |
| United Kingdom | Not on the register | MHRA, uk-mhra | 2026-09-03 |
| Canada | Authorised | Health Canada, ca-dpd | 2026-10-03 |
| Australia | Status unknown | TGA, au-artg | not read |
| Switzerland | Not on the register | Swissmedic, ch-swissmedic | 2026-09-03 |
| Brazil | Registado | ANVISA, br-anvisa | 2026-09-03 |
| Serbia | Not on the register | ALIMS, rs-alims | 2026-09-03 |
| Singapore | Not on the register | HSA, sg-hsa | 2026-09-03 |
| Turkey | Not on the register | TITCK, tr-titck | 2026-09-03 |
An EU decision applies in the 30 territories the EU register covers: its member states, and Iceland, Liechtenstein and Norway. A dashed tile has no register read for this peptide.
Side effects
Trial registerCHANGE ALERTS
Get an email when this changes
One email when the status of Glutathione changes on the register. You confirm your address first.
ENFORCEMENT AND OFFICIAL ACTIONS
1 action by named authorities
Enforcement actions, board positions and payer rules that name Glutathione, quoted from the source document. These are not approval decisions. This list shows the actions found so far. It is not a complete list: no authority publishes one.
| US-OHenforcement | Ohio Board of Pharmacy, 2026-04-16 During the inspection, [redacted] was found to possess multiple vials of the following illegal dangerous drugs, in either a white powder, purple powder, or clear liquid form, intended for injection, which were obtained from an unlicensed, foreign source: w. Glutathione 500mg, 5 vials;State of Ohio Board of Pharmacy, Order, Case No. A-2026-0037, Findings of Fact paragraph 2(w) · quoted with the party redacted |
|---|
REGISTERED TRIALS
Newest 10 of 276 trials
| NCT07304440 | Adia Med of Winter Park LLC Autism Spectrum Disorder Research Study currently recruiting participants · register updated 2026-09-22 |
|---|---|
| NCT04740580 | Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease running, but no longer enrolling · register updated 2026-09-09 |
| NCT03493178 | Glutathione in Mild Cognitive Impairment running, but no longer enrolling · register updated 2026-09-04 |
| NCT07792369 | 26DT052; Scaling Busulfan Dose to Body Surface Area in Children not yet recruiting participants · register updated 2026-08-28 |
| NCT07162623 | Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Oziva Bioactive Gluta Fizzy Effervescent Tablets on Subjects completed · register updated 2026-08-06 |
| NCT05654922 | Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant currently recruiting participants · register updated 2026-08-05 |
| NCT07748507 | Comparison of Gingival Depigmentation Using Microneedling and Microneedling With Glutathione Gel - A Split Mouth Clinical Trial completed · register updated 2026-08-05 |
| NCT07477275 | Combination of Oral and Topical Whitening Agents for Reducing Skin Pigmentation completed · register updated 2026-07-31 |
| NCT04677972 | SPI-1005 for the Treatment of Meniere's Disease completed · register updated 2026-07-23 |
| NCT07724067 | GLUT-F Improves MASLD Liver Function completed · register updated 2026-07-23 |
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.